Trial of Combination Therapy to Treat COVID-19 Infection
Status:
Active, not recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
In this trial patients will be treated with either a combination of therapies to treat
COVID-19 or a placebo. Treatment will last 10 days, and patients will be followed for 6
months.